Ameriprise
CGON icon

Ameriprise’s CG Oncology CGON Stock Holding History

Ameriprise’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.1M Buy
311,523
+71,046
+30% +$4.03M ﹤0.01% 1369
2025
Q4 		$9.98M Buy
240,477
+132,556
+123% +$5.49M ﹤0.01% 1911
2025
Q3 		$4.35M Sell
107,921
-2,535
-2% -$73.7K ﹤0.01% 2541
2025
Q2 		$2.87M Buy
110,456
+91,211
+474% +$2.2M ﹤0.01% 2750
2025
Q1 		$471K Sell
19,245
-2,701
-12% -$76K ﹤0.01% 3511
2024
Q4 		$629K Buy
21,946
+9,051
+70% +$310K ﹤0.01% 3433
2024
Q3 		$487K Buy
12,895
+2,419
+23% +$84.8K ﹤0.01% 3486
2024
Q2 		$331K Buy
+10,476
New +$363K ﹤0.01% 3563

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM